DeepView System

Dallas’ Spectral AI Appoints Chief Commercialization Officer

by | May 31, 2024

Dallas-based artificial intelligence company Spectral AI Inc. has appointed Jeremiah A. Sparks as chief commercialization officer. Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in wound care.

Sparks brings over 20 years of medical device marketing experience, including global marketing and business strategy. He will be responsible for both domestic and international product commercialization, the company said....

MORE
Spectral AI Names EVP to Spearhead UK Subsidiary, Global Expansion of Imaging Tech
by | Oct 27, 2023
Spectral AI has recently secured its largest contract to date from the U.S. government, an award exceeding $149 million, boosting its total U.S. government awards accrued since 2019 to more than $246 million, as it aims to revolutionize wound care. The company's DeepView SnapShot Wound Imaging System, has received UK Conformity Assessed (UKCA) marking for use in the United Kingdom and has been classified as a Class 1 medical device by U.S. FDA.
MORE
Spectral AI Appoints ‘High-Impact’ Healthcare Exec to its Board of Directors
by | Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.
MORE
Spectral MD Awarded BARDA Project BioShield Contract Worth Up to $149M
by | Sep 28, 2023
The contract is for the advanced development of Spectral MD's DeepView System, an AI-driven burn wound imaging device designed to be used at emergency departments, trauma centers, and burn centers.
MORE